Clinical trial
A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
NCT00448071 is registered in ClinicalTrials.gov with Wolfson Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
- Lead sponsor
- Wolfson Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2006
- Completion date
- March 31, 2007
- Enrollment
- 12
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, hypotension, intra dialytic hypotension